Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLAND PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLAND PHARMA GSK PHARMA GLAND PHARMA/
GSK PHARMA
 
P/E (TTM) x 42.6 59.5 71.6% View Chart
P/BV x 3.4 22.5 15.0% View Chart
Dividend Yield % 1.1 1.3 82.9%  

Financials

 GLAND PHARMA   GSK PHARMA
EQUITY SHARE DATA
    GLAND PHARMA
Mar-24
GSK PHARMA
Mar-24
GLAND PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2,1962,650 82.9%   
Low Rs8621,228 70.2%   
Sales per share (Unadj.) Rs343.9203.9 168.7%  
Earnings per share (Unadj.) Rs46.934.8 134.7%  
Cash flow per share (Unadj.) Rs67.838.9 174.2%  
Dividends per share (Unadj.) Rs20.0032.00 62.5%  
Avg Dividend yield %1.31.7 79.3%  
Book value per share (Unadj.) Rs529.6105.5 502.1%  
Shares outstanding (eoy) m164.71169.41 97.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.49.5 46.7%   
Avg P/E ratio x32.655.7 58.5%  
P/CF ratio (eoy) x22.549.8 45.3%  
Price / Book Value ratio x2.918.4 15.7%  
Dividend payout %42.691.9 46.4%   
Avg Mkt Cap Rs m251,781328,474 76.7%   
No. of employees `000NANA-   
Total wages/salary Rs m12,5696,244 201.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,64734,537 164.0%  
Other income Rs m1,7021,226 138.9%   
Total revenues Rs m58,35035,763 163.2%   
Gross profit Rs m13,3317,651 174.2%  
Depreciation Rs m3,446697 494.5%   
Interest Rs m26218 1,456.4%   
Profit before tax Rs m11,3258,162 138.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,6012,262 159.2%   
Profit after tax Rs m7,7255,900 130.9%  
Gross profit margin %23.522.2 106.2%  
Effective tax rate %31.827.7 114.7%   
Net profit margin %13.617.1 79.8%  
BALANCE SHEET DATA
Current assets Rs m56,45227,984 201.7%   
Current liabilities Rs m13,98415,249 91.7%   
Net working cap to sales %75.036.9 203.3%  
Current ratio x4.01.8 220.0%  
Inventory Days Days50115 43.7%  
Debtors Days Days100235 42.8%  
Net fixed assets Rs m49,6576,119 811.5%   
Share capital Rs m1651,694 9.7%   
"Free" reserves Rs m87,06016,172 538.3%   
Net worth Rs m87,22517,866 488.2%   
Long term debt Rs m1,0650-   
Total assets Rs m106,10834,103 311.1%  
Interest coverage x44.2454.7 9.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.0 52.7%   
Return on assets %7.517.4 43.4%  
Return on equity %8.933.0 26.8%  
Return on capital %13.145.8 28.7%  
Exports to sales %63.10-   
Imports to sales %022.9 0.0%   
Exports (fob) Rs m35,764NA-   
Imports (cif) Rs mNA7,912 0.0%   
Fx inflow Rs m35,7641,342 2,666.0%   
Fx outflow Rs m9,4017,912 118.8%   
Net fx Rs m26,363-6,570 -401.3%   
CASH FLOW
From Operations Rs m9,9685,820 171.3%  
From Investments Rs m-17,56987 -20,166.6%  
From Financial Activity Rs m-7,994-5,615 142.4%  
Net Cashflow Rs m-15,518292 -5,309.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 39.8 11.7 340.8%  
FIIs % 4.5 4.4 102.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 25.0 192.7%  
Shareholders   122,358 119,228 102.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLAND PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on GLAND PHARMA vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GLAND PHARMA vs GSK Pharma Share Price Performance

Period GLAND PHARMA GSK Pharma S&P BSE HEALTHCARE
1-Day 0.57% -2.67% 0.11%
1-Month 6.67% -10.45% -3.22%
1-Year 7.89% 42.93% 42.65%
3-Year CAGR -20.31% 14.09% 19.86%
5-Year CAGR -0.35% 7.44% 25.90%

* Compound Annual Growth Rate

Here are more details on the GLAND PHARMA share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of GLAND PHARMA hold a 51.8% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GLAND PHARMA and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, GLAND PHARMA paid a dividend of Rs 20.0 per share. This amounted to a Dividend Payout ratio of 42.6%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 91.9%.

You may visit here to review the dividend history of GLAND PHARMA, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.